Pilot Study to Determine Efficacy of Cyclamen Europaeum Extract Nasal Spray in Patients With Acute Sinusitis

ACUTE SINUSITIS Clinical Trial

Official title:
A Randomized, Double-blind, Placebo Controlled, Parallel Group Trial of Cyclamen Europaeum Extract Nasal Spray 10% (v/v) in the Treatment of Subjects With Acute Sinusitis

Status Completed

Clinical Trial Summary

To evaluate the efficacy and safety of Cyclamen europaeum extract 10 % (v/v) compared to placebo in subjects with acute sinusitis

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00552773
Study type	Interventional
Source	Dey
Contact
Status	Completed
Phase	N/A
Start date	November 2007
Completion date	December 2009

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05127161` - Broad Implementation of Outpatient Stewardship	N/A
Completed	`NCT01700725` - Gulf War Illness Nasal Irrigation Study	Phase 2
Active, not recruiting	`NCT06076304` - Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Sinusitis - Pilot	Phase 4
Completed	`NCT01806103` - Antimicrobial Stewardship for Primary Care Pediatricians	N/A
Completed	`NCT02297815` - Comparative Effectiveness of Antibiotics for Respiratory Infections
Terminated	`NCT04664803` - Safety and Efficacy of Cefecin Tab. in Patients With Acute Sinusitis	Phase 4